Current Report Filing (8-k)
July 26 2021 - 4:06PM
Edgar (US Regulatory)
0001382574
false
0001382574
2021-07-26
2021-07-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of Earliest Event Reported): July 26, 2021
TRxADE
HEALTH, INC.
(Exact
name of Registrant as specified in its charter)
Delaware
|
|
001-39199
|
|
46-3673928
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
3840
Land O’ Lakes Blvd
Land
O’ Lakes, Florida 34639
(Address
of principal executive offices) (zip code)
Registrant’s
telephone number, including area code: 800-261-0281
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock,
$0.00001
Par Value Per Share
|
|
MEDS
|
|
The
NASDAQ Stock Market LLC
(Nasdaq
Capital Market)
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.02
|
Results
of Operations and Financial Condition.
|
On
July 26, 2021, TRxADE HEALTH, INC., formerly Trxade Group, Inc. (“Trxade” or the “Company”) issued
a press release and will hold a conference call and webcast regarding its financial results for the three and six months ended June 30,
2021. A copy of the press release, which includes information on the conference call and webcast and a summary of such financial results
is furnished as Exhibit 99.1 to this Form 8-K.
The
information contained in this Current Report (and included as exhibits hereto) shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference
in such a filing.
The
press release furnished as Exhibit 99.1, to this Current Report on Form 8-K, contains forward-looking statements within
the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, and, as such, may involve known and unknown risks,
uncertainties and assumptions. These forward-looking statements relate to the Company’s current expectations and are subject to
the limitations and qualifications set forth in the press release as well as in the Company’s other filings with the Securities
and Exchange Commission, including, without limitation, that actual events and/or results may differ materially from those projected
in such forward-looking statements. These statements also involve known and unknown risks, which may cause the results of the Company,
its divisions and concepts to be materially different than those expressed or implied in such statements. Accordingly, readers should
not place undue reliance on any forward-looking statements. Forward-looking statements may include comments as to the Company’s
beliefs and expectations as to future financial performance, events and trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the Company’s control. More information on potential factors that could affect the Company’s
financial results is included from time to time in the “Forward-Looking Statements,” “Risk Factors”
and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the
Company’s periodic and current filings with the SEC, including the Form 10-Qs and Form 10-Ks, filed with the SEC and available
at www.sec.gov and in the “NASDAQ:MEDS” — “SEC Filings” section of the Company’s website
at https://www.trxadegroup.com/investors, and specifically including the Company’s Annual Report on Form 10-K for the year
ended December 31, 2021 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2021. Forward-looking statements speak only
as of the date they are made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise that occur after that date, except as otherwise provided by law.
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
TRXADE
HEALTH, INC.
|
|
|
Date:
July 26, 2021
|
By:
|
/s/
Suren Ajjarapu
|
|
Name:
|
Suren
Ajjarapu
|
|
Title:
|
Chief
Executive Officer
|
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Aug 2024 to Sep 2024
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Sep 2023 to Sep 2024